Stanford University Regional Coordinating Stroke Center for the NIH Stroke Trials Network

斯坦福中风中心是最早的综合性多学科中心之一， 成立于1992年，旨在开发诊断和治疗中风的新方法。卒中中心的使命 是成为美国最好的综合性组织，专注于中风的诊断、治疗、 研究和教育。1992年，该中心由一组神经学家、神经外科医生、 神经放射科医生、护理专家、基础科学家和临床研究人员。这个多学科的团队有 定期开会，在25年内不断完善该计划。2012年，联合委员会和美国 心脏协会/美国中风协会宣布，斯坦福中风中心是第一个 美国一家医院将达到联合委员会的疾病专科护理标准 全面卒中中心认证。 斯坦福大学被选为最早的StrokeNet区域协调中心(RCC)之一。在.期间 在最初的资助期间，斯坦福大学开发了FUSE 3研究，这成为第一个得到资助的临床试验 并由StrokeNet执行。这一40个地点的试验非常成功；入学率为 大大超过了预计的目标，试验被dsmb提前停止，因为 血管内治疗组的有效概率。斯坦福大学的地区网络是全美注册人数最多的大学之一 StrokeNet的研究和斯坦福大学的教职员工为StrokeNet的主要委员会做出了重大贡献。这个 斯坦福-RCC将继续为NINDS提供大量不同患者群体的登记 资助中风试验。斯坦福RCC还将继续提供创新的多学科奖学金 该计划提供临床试验设计、实施和分析方面的全面培训。此外, 斯坦福大学的教职员工将继续通过StrokeNet提出新的临床试验方案。

The Stanford Stroke Center, one of the first comprehensive multidisciplinary centers of its kind, was established in 1992 to develop new approaches to diagnose and treat stroke. The mission of the Stroke Center is to be the best comprehensive organization in the United States focused on stroke diagnosis, treatment, research, and education. In 1992, the Center was established by a team of neurologists, neurosurgeons, neuroradiologists, nurse specialists, basic scientists, and clinical researchers. This multi-disciplinary team has met regularly to continually refine the program for 25 years. In 2012, the Joint Commission and the American Heart Association/American Stroke Association announced that the Stanford Stroke Center was the first hospital in the United States to meet The Joint Commission's standards for Disease-Specific Care Comprehensive Stroke Center Certification. Stanford was chosen to be one of the original StrokeNet Regional Coordinating Centers (RCCs). During the initial grant period, Stanford developed the DEFUSE 3 study, which became the first clinical trial to be funded and executed by StrokeNet. This 40-site trial has been extremely successful; enrollment rates were substantially ahead of projected targets and the trial was stopped early by the DSMB because of a high probability of efficacy in the endovascular group. Stanford's regional network is one of the highest enrollers in StrokeNet studies and Stanford faculty have made major contributions to key StrokeNet committees. The Stanford-RCC will continue to provide high volume enrollment of diverse patient populations into NINDS funded stroke trials. The Stanford RCC will also continue to offer an innovative multidisciplinary fellowship program that provides comprehensive training in clinical trial design, implementation and analysis. In addition, Stanford faculty members will continue to propose new clinical trials for implementation through StrokeNet.